Global High Oleic Soybean Market 2019 Industry Key Players, Trends, Sales, Supply, Demand, Analysis & Forecast 2025

Apr 4, 2019

WiseGuyReports.com adds “High Oleic Soybean Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting 2025” reports to its database.

Pune, India - April 4, 2019 /MarketersMedia/ —

High Oleic Soybean Market:

Executive Summary

The global High Oleic Soybean market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the High Oleic Soybean market based on company, product type, end user and key regions.

This report studies the global market size of High Oleic Soybean in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of High Oleic Soybean in these regions.

This research report categorizes the global High Oleic Soybean market by top players/brands, region, type and end user. This report also studies the global High Oleic Soybean market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Monsanto
Dupont Pioneer
Syngenta
Dow
Bayer
Calyxt
Market size by Product

GMO
Non-GMO
Market size by End User

Agriculture
Food
Others
The study objectives of this report are:

To study and analyze the global High Oleic Soybean market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of High Oleic Soybean market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global High Oleic Soybean companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of High Oleic Soybean submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of High Oleic Soybean are as follows:

History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of High Oleic Soybean market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/3891251-global-high-oleic-soybean-market-insights-forecast-to-2025

Table of Contents

1 Study Coverage
1.1 High Oleic Soybean Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global High Oleic Soybean Market Size Growth Rate by Product
1.4.2 GMO
1.4.3 Non-GMO
1.5 Market by End User
1.5.1 Global High Oleic Soybean Market Size Growth Rate by End User
1.5.2 Agriculture
1.5.3 Food
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global High Oleic Soybean Market Size
2.1.1 Global High Oleic Soybean Revenue 2014-2025
2.1.2 Global High Oleic Soybean Sales 2014-2025
2.2 High Oleic Soybean Growth Rate by Regions
2.2.1 Global High Oleic Soybean Sales by Regions
2.2.2 Global High Oleic Soybean Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 High Oleic Soybean Sales by Manufacturers
3.1.1 High Oleic Soybean Sales by Manufacturers
3.1.2 High Oleic Soybean Sales Market Share by Manufacturers
3.1.3 Global High Oleic Soybean Market Concentration Ratio (CR5 and HHI)
3.2 High Oleic Soybean Revenue by Manufacturers
3.2.1 High Oleic Soybean Revenue by Manufacturers (2014-2019)
3.2.2 High Oleic Soybean Revenue Share by Manufacturers (2014-2019)
3.3 High Oleic Soybean Price by Manufacturers
3.4 High Oleic Soybean Manufacturing Base Distribution, Product Types
3.4.1 High Oleic Soybean Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers High Oleic Soybean Product Type
3.4.3 Date of International Manufacturers Enter into High Oleic Soybean Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global High Oleic Soybean Sales by Product
4.2 Global High Oleic Soybean Revenue by Product
4.3 High Oleic Soybean Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global High Oleic Soybean Breakdown Data by End User

…

11 Company Profiles
11.1 Monsanto
11.1.1 Monsanto Company Details
11.1.2 Company Business Overview
11.1.3 Monsanto High Oleic Soybean Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Monsanto High Oleic Soybean Products Offered
11.1.5 Monsanto Recent Development
11.2 Dupont Pioneer
11.2.1 Dupont Pioneer Company Details
11.2.2 Company Business Overview
11.2.3 Dupont Pioneer High Oleic Soybean Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Dupont Pioneer High Oleic Soybean Products Offered
11.2.5 Dupont Pioneer Recent Development
11.3 Syngenta
11.3.1 Syngenta Company Details
11.3.2 Company Business Overview
11.3.3 Syngenta High Oleic Soybean Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Syngenta High Oleic Soybean Products Offered
11.3.5 Syngenta Recent Development
11.4 Dow
11.4.1 Dow Company Details
11.4.2 Company Business Overview
11.4.3 Dow High Oleic Soybean Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Dow High Oleic Soybean Products Offered
11.4.5 Dow Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Company Business Overview
11.5.3 Bayer High Oleic Soybean Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Bayer High Oleic Soybean Products Offered
11.5.5 Bayer Recent Development
11.6 Calyxt
11.6.1 Calyxt Company Details
11.6.2 Company Business Overview
11.6.3 Calyxt High Oleic Soybean Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Calyxt High Oleic Soybean Products Offered
11.6.5 Calyxt Recent Development

Continuous…

For further information on this report, visit – https://www.wiseguyreports.com/enquiry/3891251-global-high-oleic-soybean-market-insights-forecast-to-2025

Contact Info:
Name: Norah Trend
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Pune - 411028 Maharashtra, India
Phone: +1 (339) 368 6938 (US), +44 208 133 9349 (UK)
Website: https://www.wiseguyreports.com/reports/3891251-global-high-oleic-soybean-market-insights-forecast-to-2025

Source URL: https://marketersmedia.com/global-high-oleic-soybean-market-2019-industry-key-players-trends-sales-supply-demand-analysis-forecast-2025/498856

Source: MarketersMedia

Release ID: 498856

More News

Are the AI industry’s apocalyptic warnings just a marketing ploy?

Oct 9, 2026

Are the AI industry’s apocalyptic warnings just a marketing ploy?

Anthropic CEO Dario Amodei told the UN that if “managed poorly,” AI models “could be a risk to humanity as a whole.” | John Lamparski/Bloomberg via Getty Images Silicon Valley has long warned that its favorite technology might get us all killed. But chatter about AI’s apocalyptic potential has grown louder in recent weeks. In September, Anthropic researcher Jacob Coxon resigned from the company, accusing his former employer of “gambling with our lives” by developing evermore powerful models faster than it could control them. One of Coxon’s former colleagues vouched for this assessment, saying that there was a greater than 10 percent chance of AI “killing all humans” within the next decade. Recent pronouncements from the leaders of these companies have been nearly as grim. At the United Nations last month, Anthropic CEO Dario Amodei warned that, if “managed poorly,” AI models “could be a risk to humanity as a whole.” OpenAI’s Sam Altman similarly declared that our species just might “lose control of the future” to the type of software that his firm is selling. All this triggered a tsunami of media coverage and policy debate about the “existential risks” of AI — and what, if anything, we can do about them. Key takeaways Some critics argue that AI leaders’ warnings about existential risk are a PR strategy to attract investment, distract from present-day harms, and shape regulation in their favor. But this theory doesn’t make a ton of sense. The simpler explanation is that many AI executives, researchers, and defectors genuinely believe the technology poses catastrophic risks, based on real trends in AI’s growing power and autonomy. Yet some of the AI industry’s biggest critics are more annoyed than afraid. As they see it, the world isn’t trembling on the precipice of robo-annihilation, so much as falling for the tricks of snake oil salesmen. This argument has been percolating for years, voiced by a broad set of observers, including the linguist Emily Bender (“It makes the product seem more powerful”), computer scientist Timnit Gebru (“It’s not just a distraction, but it’s harmful”), as well as Substack columnist Ed Zitron and various reporters and social media influencers. In their thinking, Altman and Amodei aren’t talking up their technology’s catastrophic potential because they’re rationally afraid of where AI is going — they’re doing so because their firms are ravenously hungry for more investment. And the reason why “AI doom” has grown more salient in recent weeks isn’t that the case for concern has gotten stronger, but rather that OpenAI and Anthropic’s IPOs have gotten closer. In short, these Big Tech skeptics argue, journalists and politicians have fallen prey to a counterintuitive PR strategy, one that stokes media frenzies over ludicrous sci-fi scenarios in order to hype AI’s technological promise, distract attention from chatbots’ present-day harms, and help labs secure favorable regulatory treatment. This would be reassuring, if true. Unfortunately, the theory is unpersuasive. There is little reason to believe that the panic over AI’s “existential risks” was cooked up in a Silicon Valley marketing department. To the contrary, the most plausible explanation for the AI sector’s doomsaying is also the most straightforward: Many of the industry’s executives, employees, and analysts genuinely believe that AI progress poses catastrophic risks.  In my conversations with close observers of the industry, even some of OpenAI and Anthropic’s fiercest detractors conceded that their leaders’ avowed concerns are unlikely to be mere marketing tactics. “The more I learn about the underlying ideologies out of which those two labs were formed, the more I think what we have here is a sincere belief,” the author and computer scientist Cal Newport told me.  This does not mean that Amodei and Altman are right, much less that we can trust in their judgment or integrity. There are many reasons to doubt that the weather forecast for 2036 is “cloudy with a chance of robot apocalypse,” or that anyone can assign a “10 percent” probability to the latter outcome without pulling numbers out of thin air. Nevertheless, Silicon Valley’s Cassandras have some logic and evidence on their side. AI models are growing both more capable, autonomous, and arguably unruly. If these trends continue unchecked, it’s not hard to see how they could yield very bad outcomes. Given the stakes, we should not be comfortable dismissing their warnings on dubious grounds. And the “PR” theory of AI doom does precisely that. How AI companies (supposedly) profit off fears of the robot apocalypse Before examining why AI “doomerism” probably isn’t a PR stunt, it’s worth saying a bit more about why some believe that is. According to Bender, Gebru, and others, AI companies benefit from talk of artificial intelligence’s existential risks in at least three ways. First, it attracts investment. In the words of The Atlantic’s Matteo Wong, the doomer narrative implies that AI labs’ models are “destined to become terrifyingly capable,” and thus massively profitable. As the Los Angeles Times’s Brian Merchant put the point during the first big wave of AI panic in 2023, “what better way to generate a buzz than to insist, with a certain presumed credibility, that your new technology is so potent it might unravel the world as we know it?”  “If you position these threats as all-powerful, as somewhat unknowable, you get to be the expert on it.” Kate Brennan, AI Now Institute Second, hyping AI’s hypothetical future hazards diverts attention from the companies’ current malfeasance. Every minute we spend debating whether AI will one day turn us all into paper clips is a minute we aren’t discussing the AI labs’ alleged copyright violations, pollution, labor violations, and myriad other social harms.  And third, the doom narrative shifts regulatory scrutiny away from topics that directly threaten the AI companies’ profitability — such as copyright enforcement — while also suggesting that regulators must rely on the labs themselves for guidance.  “If you position these threats as all-powerful, as somewhat unknowable, you get to be the expert on it,” Kate Brennan of the AI Now Institute, a progressive think tank focused on artificial intelligence’s near-term harms, told me. Critically, for the biggest skeptics of “AI doom,” industry executives and employees aren’t the only ones complicit in this PR strategy. Self-styled whistleblowers like Coxon are also suspect, since they might be “using the spotlight to attract funding to start a new venture or to secure new positions.” And even nonprofit AI safety organizations are thought to function as vessels for Big Tech’s marketing campaigns, a fact reflected by the financial and interpersonal ties between the major labs and such think tanks.  There are better ways to raise money than promising to end the world The “PR” critique of AI doomerism has some kernels of truth. AI companies probably would prefer to talk about their technology’s hypothetical future dangers than about their products’ present-day harms. And if publicly touting AI’s existential risks were antithetical to Anthropic and OpenAI’s business goals, their leaders would almost certainly say less in public about that subject. (Disclosure: Vox Media is one of several publishers that have signed partnership agreements with OpenAI. Our reporting remains editorially independent.) But it does not follow that Altman and Amodei’s warnings are a self-conscious marketing strategy, born of cynical calculation rather than genuine concern. And there are several reasons to doubt that charge. For one thing, AI companies have no shortage of ways to hype up their technology’s capabilities. And it is hard to see how any firm could conclude that the optimal approach — from a purely financial standpoint — would be to portray itself as a threat to human survival. For investors, the appeal of AI companies is not that they could hypothetically get us all enslaved by a machine God; it’s that they could theoretically make a lot of money.  Perhaps casting your chatbots as an “existential” risk will persuade some capitalists of your future profitability. But this seems like an awfully indirect pitch — and one that’s almost certain to be less effective than demonstrating that a lot of corporations would like to rent your software.   “If these guys were selling flypaper — and the revenue was growing as fast as it is — investors would be more or less just as interested,” Roy Bahat, the head of Bloomberg’s venture capital arm, told me. And even if these firms were hellbent on awing the public with grandiose predictions of their technology’s future powers, they’d have little need to invoke the robot apocalypse. Touting AI’s potential to cure cancer, abolish poverty, or facilitate intergalactic travel would all seem to advance the same objective, while doing less to jeopardize the companies’ public reputations or freedom from intrusive regulation. And in fact, many with a vested interest in the major AI labs’ success talk up the technology in precisely this way. OpenAI investor Marc Andreessen has decried AI safety concerns as a “full-blown moral panic” while insisting that artificial intelligence will empower humanity to cure all diseases and engage in “interstellar travel.” Similarly, Jensen Huang, the CEO of chipmaker Nvidia and major investor in both OpenAI and Anthropic, has called claims of AI’s catastrophic potential “complete nonsense.” If hyping AI doom is essential for stoking investment, not everyone in Silicon Valley has gotten the memo. The media doesn’t seem that distracted Promoting fears of AI’s existential risks would be a similarly odd approach to media management. Without question, corporations always seek to direct news coverage away from their greatest legal and ethical liabilities. But companies can try to secure more favorable press in many different ways. And implicating themselve

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

The Daily Feeder

A leading news network dedicated to keeping you up-to-date on the world's most important political, business, and cultural news into a three-minute read.

NEWSLETTER